Severed Clause definition

Severed Clause. Has the meaning set forth in Section 8.3.

Severed Clause shall have the meaning as defined in Section 14.11

Severed Clause shall have the meaning set forth in Section 9.4.

Examples of Severed Clause in a sentence

• The Parties shall consult and use reasonable efforts to agree upon a valid and enforceable provision that shall be a reasonable substitute for such Severed Clause in light of the intent of this Agreement.

• The Parties shall consult and use their best efforts to agree upon a valid and enforceable provision that shall be a reasonable substitute for such Severed Clause in light of the intent of this Agreement.

• If, under applicable law or regulation, any provision of this Agreement is invalid or unenforceable, or otherwise directly or indirectly affects the validity of any other material provision(s) of this Agreement (“Severed Clause”), the Parties agree that this Agreement is intended to endure except for the Severed Clause.

• The parties shall consult and use their reasonable efforts to agree upon a valid and enforceable provision that shall be a reasonable substitute for such Severed Clause in light of the intent of this Agreement.

• If, under applicable law or regulation, any provision of this Agreement is invalid or unenforceable, or otherwise directly or indirectly affects the validity of any other material provision(s) of this Agreement (“Severed Clause”), the parties hereto agree that this Agreement is intended to endure except for the Severed Clause.

More Definitions of Severed Clause

Severed Clause has the meaning set forth in Section 18.03 (Severability) hereof.

Severed Clause is defined in Section 21.7.

Severed Clause has the meaning set forth in Section 10.11.

Severed Clause. Has the meaning set forth in Section 7.3. Commented [GSS4]: QUESTION FOR ICANN: Has a proposed name been circulated yet? Formatted: Underline

Severed Clause. Has the meaning set forth in Section 7.3. COMMUNITY COORDINATION GROUP

Severed Clause shall have the meaning set forth in Section 12.8. 1.43 “Specifications” shall mean (a) with respect to the bulk Licensed Product, the specifications for the bulk Licensed Product, as determined pursuant to the Elan Supply Agreement and Section 6.3 of the Elan License Agreement and as may be amended in accordance with Section 5.1 of this Agreement, and (b) with respect to the packaging and labeling for orders of the Licensed Product for sale in a particular country in the Territory, the specifications therefor mutually agreed upon by the Parties in accordance with Section 5.1(b). 1.44 “Supply Shortage” shall have the meaning set forth in Section 4.7. 1.45 “Term” shall have the meaning set forth in Section 10.1. 1.46 “Third Party” shall mean any Person who is not a Party or an Affiliate under this Agreement. 1.47 “Transfer Price” shall mean the price Acorda’s Third Party manufacturer(s) invoices Acorda for Product Manufactured by such Third Party manufacturer(s) supplied to Licensee pursuant to the agreement(s) between Acorda and such manufacturer(s). 1.48

Severed Clause shall have the meaning set forth in Section 20.7. "Shared Promotion Expenses" shall mean, with respect to each IL-1 Product, Out-of-Pocket Costs and other costs (in the case of personnel costs for personnel directly involved in the marketing or promotional activities, determined based on the FTE Rate or such other basis as may otherwise be agreed by the Parties) which are incurred by a Party or any of its Affiliates to the extent consistent with the Consolidated Co-Commercialization Budget included in the then applicable Consolidated Co-Commercialization Plan and related to the Co-Commercialization of such IL-1 Product, including, without limitation, costs in the following categories: (a) costs incurred in promoting and marketing such IL-1 Product, including without limitation, advertising (including agency fees), market research, patient-oriented promotions, meetings, pre-Launch activities and expenses relating to launch of the IL-1 Product, and managed markets/health authority liaisons (but excluding Detailing expenses); (b) amounts repaid or credited for bad debts; (c) costs associated with post-marketing drug safety surveillance; (d) medical affairs costs, and costs associated with medical/scientific liaisons (including regional scientific directors), medical education and publications, professional symposia, advisory boards, speaker and activity programs; (e) costs of Phase IV Clinical Trials in the Co-Commercialization Countries (excluding costs associated with any Phase IV Clinical Trials intended to support or maintain a Registration Filing for such IL-1 Product, including by way of example to support expanded labeling for such IL-1 Product, or to satisfy requirements imposed by Regulatory Authorities in connection with Approvals for such IL-1 Product, all of which are included in Development Costs) and pharmacoeconomic studies; -16- <PAGE> (f) the cost of samples; (g) costs of materials and programs for the training of sales force, regional sales management and marketing management; (h) costs of Promotional Materials, telemarketing, e-marketing, field and headquarters' grants, exhibits, direct mail and sample alternative programs; (i) costs associated with global sales force training agreed by the JOC; provided, however, that each Party will train its own sales force (and that of its Affiliates) at its own expense; (j) amounts paid by way of milestones or royalties due under any Existing License or New License with respect to sales of such IL-1 Pr...